在血症新生儿中, gentamicin 治疗失败的预测因素
Bonifasius Siyuka Singu1, Clarissa Hildegard Pieper2, Roger Karel Verbeeck1
1School of Pharmacy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia.
Pharmacology research & perspectives
|August 6, 2024
概括
在新生儿败血症中,因治疗时间较长,C反应性蛋白质较高,出生体重或白细胞数量较低而预测Gentamicin治疗失败. 这些因素有助于识别患有治疗失败风险的新生儿.
科学领域:
- 新生儿医学 新生儿医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症对新生儿构成重大威胁,其中格拉姆阴性细菌是主要原因.
- 甘他是早期新生儿败血症的常见抗生素,但治疗失败发生.
- 识别 gentamicin 失败的预测因素对于改善新生儿结果至关重要.
研究的目的:
- 为了确定在被诊断为败血症的新生儿中 gentamicin 治疗失败的预测因素.
- 分析影响新生儿败血症治疗结果的因素.
主要方法:
- 在新生儿重症监护病房进行了前性横截面研究.
- 使用后勤回归建模来确定治疗失败的预测因素.
- 收集的数据包括治疗持续时间,C反应蛋白 (CRP),白细胞 (WBC) 计数和出生体重.
主要成果:
- 36%的新生儿经历了 gentamicin 治疗失败.
- 治疗持续时间的延长和CRP水平的升高与治疗失败的几率更高有关.
- 较高的出生体重和较高的白细胞计数与治疗失败的几率降低有关.
结论:
- 长时间的治疗时间,高CRP,低出生体重和低白血球数量是新生儿 جنت米辛治疗失败的重要预测因素.
- 这些发现可以帮助新生儿败血症的风险分层和管理.
- 进一步的研究可能会探索高风险新生儿的替代治疗策略.
相关概念视频
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urine Studies II: Urine Culture and Sensitivity Test
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...


